High Hampton Holdings (CSE:HC,OTC:HHPHF,FSE:OHCN) CEO Gary Latham joined the Midas Letter to discuss the company’s recent shift in business strategy and its investment in the 2083 Group Inc. High Hampton will be focusing on developing cannabis products and brands due to their higher margins.

High Hampton has a 15,000-square-foot facility in Cudahy, California. It has six licenses for the facility, which will allow High Hampton to distribute medical and recreational cannabis throughout the state. According to Latham, the facility will provide a foundation for the company. It will house the company’s nursery, distribution, non-storefront retail, edibles kitchen and manufacturing capabilities once the facility is fully operational. High Hampton’s delivery license will play an essential role in future business operations as it allows the company to enter counties and municipalities that have otherwise restricted retail cannabis operations.

Latham also talked about the company’s CaliGold and Mojave Jane brands. High Hampton is already shipping products and recently released new products for their CaliGold edibles brand. Latham pointed out that the CaliGold brand has done well in California’s market.

High Hampton has also gained a minority interest in the 2083 Group. The 2083 Group developed the Speedweed delivery platform, an on-demand cannabis delivery service with a consumer database of over 250,000 consumers throughout California. Speedweed currently works with 10 dispensaries in the state and is growing rapidly. There are approximately 800 dispensaries throughout California, and they only cover a small area. Latham stated that High Hampton is aiming to service those who do not have a dispensary near them. The investment also offers High Hampton the opportunity to access market data, understand consumer demands and to develop products and brands that meet those demands.

To watch the full interview, click here.

Click here to connect with High Hampton Holdings Corp (CSE:HC, OTC:HHPHF, FSE:OHCN) for an Investor Presentation. 

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less


Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less